{
    "applicationNumber": "BR 11 2022 026429-1",
    "filingDate": "22/06/2021",
    "grantDate": null,
    "title": "ANTICORPO ANTI-CD2 RECOMBINANTE, SEQU\u00caNCIA DE \u00c1CIDO NUCLEICO, FORMULA\u00c7\u00c3O FARMAC\u00caUTICA, M\u00c9TODO PARA TRATAR UM DIST\u00daRBIO CR\u00d4NICO DO SISTEMA IMUNE, M\u00c9TODO PARA MANTER TOLER\u00c2NCIA IMUNE A UM TRANSPLANTE EM UM RECEPTOR DE TRANSPLANTE E M\u00c9TODO PARA TRATAR OU PREVENIR UM DIST\u00daRBIO OU UMA DOEN\u00c7A IMUNE",
    "nationalPhaseDate": [
        "22/12/2022"
    ],
    "internationalApplication": {
        "pctNumber": "PCT EP2021/066989",
        "pctDate": "22/06/2021",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "63/042,844",
            "priorityDate": "23/06/2020"
        },
        {
            "countryCode": "US",
            "priorityNumber": "63/135,381",
            "priorityDate": "08/01/2021"
        },
        {
            "countryCode": "US",
            "priorityNumber": "63/182,095",
            "priorityDate": "30/04/2021"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2713"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2728"
        }
    ],
    "inventors": [
        "DAVID BERGLUND",
        "ERIK BERGLUND",
        "FELIX SELLBERG",
        "CHRISTIAN BINDER"
    ],
    "holders": [
        333440
    ],
    "ipcCodes": [
        "A61K 39/395",
        "A61K 38/17",
        "A61P 37/06",
        "C07K 16/28"
    ]
}